Objective: Exemplified by data of the Kiel Obesity Prevention Study (KOPS), different methods to control for response bias and to assess representativity were compared. Methods: 4,997 cross-sectional data of 5- to 7-year-old German children (main cohort) were investigated between 1996 and 2001 within school entry examination. A subgroup responded to a questionnaire to socio-demographic and lifestyle factors (responders, n = 2,631). Representativity of the main cohort was tested in comparison to the total population. To control for response bias within the responders a non-response analysis as well as an analysis of missing values were performed. Results: The comparison with the total population showed a higher prevalence of obese boys and girls from families of low socio-economic status (SES) within the main cohort. The responders were less frequently obese and overweight and more rarely belonged to low SES families when compared with non-responders. Analysis of missing values did not detect any further biases. According to an epidemiological assessment of differences the main cohort of KOPS is suggested to be representative for all 5- to 7-year-old children in Kiel, whereas the responders can be at best called ‘relatively’ representative. Conclusion: The analysis of non-response is the most sensitive method to detect group differences, but a comparison with the total population can also be used to control for biases. In addition representativity has to be proven not only for the main cohort but also for the subgroup of responders with which data analysis will be done.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.